MinutePhrase@lemmy.mlM to Science@lemmy.ml · 5 years agoCRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improvedwww.nejm.orgexternal-linkmessage-square0linkfedilinkarrow-up10arrow-down10
arrow-up10arrow-down1external-linkCRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improvedwww.nejm.orgMinutePhrase@lemmy.mlM to Science@lemmy.ml · 5 years agomessage-square0linkfedilink
